يعرض 1 - 10 نتائج من 64 نتيجة بحث عن '"A Gelibter"', وقت الاستعلام: 1.13s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%

    المؤلفون: Cortellini A., Tiseo M., Banna G. L., Cappuzzo F., Aerts J. G. J. V., Barbieri F., Giusti R., Bria E., Cortinovis D., Grossi F., Migliorino M. R., Galetta D., Passiglia F., Santini D., Berardi R., Morabito A., Genova C., Mazzoni F., Di Noia V., Signorelli D., Tuzi A., Gelibter A., Marchetti P., Macerelli M., Rastelli F., Chiari R., Rocco D., Gori S., De Tursi M., Mansueto G., Zoratto F., Santoni M., Tudini M., Rijavec E., Filetti M., Catino A., Pizzutilo P., Sala L., Citarella F., Marco R., Torniai M., Cantini L., Targato G., Sforza V., Nigro O., Ferrara M. G., D'Argento E., Buti S., Bordi P., Antonuzzo L., Scodes S., Landi L., Guaitoli G., Baldessari C., Della Gravara L., Dal Bello M. G., Belderbos R. A., Bironzo P., Carnio S., Ricciardi S., Grieco A., De Toma A., Proto C., Friedlaender A., Cantale O., Ricciuti B., Addeo A., Metro G., Ficorella C., Porzio G.

    المساهمون: Cortellini A., Tiseo M., Banna G.L., Cappuzzo F., Aerts J.G.J.V., Barbieri F., Giusti R., Bria E., Cortinovis D., Grossi F., Migliorino M.R., Galetta D., Passiglia F., Santini D., Berardi R., Morabito A., Genova C., Mazzoni F., Di Noia V., Signorelli D., Tuzi A., Gelibter A., Marchetti P., Macerelli M., Rastelli F., Chiari R., Rocco D., Gori S., De Tursi M., Mansueto G., Zoratto F., Santoni M., Tudini M., Rijavec E., Filetti M., Catino A., Pizzutilo P., Sala L., Citarella F., Marco R., Torniai M., Cantini L., Targato G., Sforza V., Nigro O., Ferrara M.G., D'Argento E., Buti S., Bordi P., Antonuzzo L., Scodes S., Landi L., Guaitoli G., Baldessari C., Della Gravara L., Dal Bello M.G., Belderbos R.A., Bironzo P., Carnio S., Ricciardi S., Grieco A., De Toma A., Proto C., Friedlaender A., Cantale O., Ricciuti B., Addeo A., Metro G., Ficorella C., Porzio G.

    مصطلحات موضوعية: Bone metastase, Liver metastase, PD-L1, Performance statu, Radiotherapy, Smoking statu, Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Female, Human, Lung Neoplasm, Male, Middle Aged, Progression-Free Survival, Retrospective Studies

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32474768; info:eu-repo/semantics/altIdentifier/wos/WOS:000536438800001; volume:69; issue:11; firstpage:2209; lastpage:2221; numberofpages:13; journal:CANCER IMMUNOLOGY, IMMUNOTHERAPY; http://hdl.handle.net/2318/1839648Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085868267

    الإتاحة: https://doi.org/10.1007/s00262-020-02613-9Test
    http://hdl.handle.net/2318/1839648Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

    المؤلفون: Landi L., D'Inca F., Gelibter A., Chiari R., Grossi F., Delmonte A., Passaro A., Signorelli D., Gelsomino F., Galetta D., Giannarelli D., Soto Parra H., Minuti G., Tiseo M., Migliorino M. R., Cognetti F., Toschi L., Bidoli P., Piantedosi F., Calabro' L., Cappuzzo F.

    المساهمون: Landi, L, D'Inca, F, Gelibter, A, Chiari, R, Grossi, F, Delmonte, A, Passaro, A, Signorelli, D, Gelsomino, F, Galetta, D, Giannarelli, D, Soto Parra, H, Minuti, G, Tiseo, M, Migliorino, M, Cognetti, F, Toschi, L, Bidoli, P, Piantedosi, F, Calabro', L, Cappuzzo, F

    مصطلحات موضوعية: Bone metastase, Immunotherapy, Nivolumab, Non-small-cell lung cancer, PD-L1, Bone metastases, Adult, Aged, 80 and over, Antineoplastic Agents, Immunological, Biomarkers, Tumor, Bone Neoplasms, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Cohort Studies, Female, Humans, Lung Neoplasms, Male, Middle Aged, Prognosis, Treatment Outcome, Molecular Targeted Therapy

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31752994; info:eu-repo/semantics/altIdentifier/wos/WOS:000501612400007; volume:7; issue:1; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; http://hdl.handle.net/10281/281350Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85075518457

    الإتاحة: https://doi.org/10.1186/s40425-019-0793-8Test
    http://hdl.handle.net/10281/281350Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis

    المؤلفون: G. Comi, Mauro Comola, Raffaella Chieffo, Letizia Leocani, Stefano Gelibter, Marco Pisa, Antonino Giordano

    المساهمون: Pisa, M., Chieffo, R., Giordano, A., Gelibter, S., Comola, M., Comi, G., Leocani, L.

    المصدر: Clinical Neurophysiology. 131:401-405

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Multiple Sclerosis, 050105 experimental psychology, 03 medical and health sciences, 0302 clinical medicine, Physical medicine and rehabilitation, Physiology (medical), Reaction Time, medicine, Humans, Multiple sclerosi, 0501 psychology and cognitive sciences, Motor evoked potential, Remyelination, Latency (engineering), Evoked potential, Progressive multiple sclerosis, Dexterity, Disability, Electromyography, business.industry, Multiple sclerosis, 05 social sciences, Middle Aged, Evoked Potentials, Motor, medicine.disease, Sensory Systems, Treatment Outcome, medicine.anatomical_structure, Neurology, Corticospinal tract, Cohort, Arm, Ambulation, Upper limb, Female, Neurology (clinical), business, 030217 neurology & neurosurgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f589ba37ac2631773a80a6f9d32f4796Test
    https://doi.org/10.1016/j.clinph.2019.11.024Test


    أضف إلى المفضلة
  4. 4
    Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis

    المؤلفون: Vittorio Martinelli, Tommaso Croese, Stefano Gelibter, Roberto Furlan, Marco Pisa, Massimo Filippi, Francesca Sangalli, Giancarlo Comi, Alessandra Mandelli, Annamaria Finardi, Bruno Colombo

    المساهمون: Gelibter, S., Pisa, M., Croese, T., Finardi, A., Mandelli, A., Sangalli, F., Colombo, B., Martinelli, V., Comi, G., Filippi, M., Furlan, R.

    المصدر: Annals of neurologyReferences. 90(2)

    مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Myeloid, Cohort Studies, Young Adult, Cerebrospinal fluid, Multiple Sclerosis, Relapsing-Remitting, Cell-Derived Microparticles, Predictive Value of Tests, Internal medicine, medicine, Humans, Myeloid Cells, Prospective Studies, Microglia, medicine.diagnostic_test, business.industry, Multiple sclerosis, Hazard ratio, Magnetic resonance imaging, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Microvesicles, medicine.anatomical_structure, Neurology, Disease Progression, Biomarker (medicine), Female, Neurology (clinical), business, Biomarkers, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85252dbe1467f9fcac616ca756f4df03Test
    https://pubmed.ncbi.nlm.nih.gov/34216397Test


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

    المؤلفون: Buti S., Bersanelli M., Perrone F., Tiseo M., Tucci M., Adamo V., Stucci L. S., Russo A., Tanda E. T., Spagnolo F., Rastelli F., Pergolesi F., Santini D., Russano M., Anesi C., Giusti R., Filetti M., Marchetti P., Botticelli A., Gelibter A., Occhipinti M. A., Ferrari M., Vitale M. G., Nicolardi L., Chiari R., Rijavec E., Nigro O., Tuzi A., De Tursi M., Di Marino P., Conforti F., Queirolo P., Bracarda S., Macrini S., Gori S., Zoratto F., Veltri E., Di Cocco B., Mallardo D., Santoni M., Patruno L., Porzio G., Ficorella C., Pinato D. J., Ascierto P. A., Cortellini A.

    المساهمون: Buti, S., Bersanelli, M., Perrone, F., Tiseo, M., Tucci, M., Adamo, V., Stucci, L. S., Russo, A., Tanda, E. T., Spagnolo, F., Rastelli, F., Pergolesi, F., Santini, D., Russano, M., Anesi, C., Giusti, R., Filetti, M., Marchetti, P., Botticelli, A., Gelibter, A., Occhipinti, M. A., Ferrari, M., Vitale, M. G., Nicolardi, L., Chiari, R., Rijavec, E., Nigro, O., Tuzi, A., De Tursi, M., Di Marino, P., Conforti, F., Queirolo, P., Bracarda, S., Macrini, S., Gori, S., Zoratto, F., Veltri, E., Di Cocco, B., Mallardo, D., Santoni, M., Patruno, L., Porzio, G., Ficorella, C., Pinato, D. J., Ascierto, P. A., Cortellini, A.

    مصطلحات موضوعية: Antibiotic, Cancer patient, Concomitant medication, Corticosteroid, Drug, Immune checkpoint inhibitor, Immunotherapy, Index, Prognostic, Proton-pump inhibitor, Score, Adult, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Female, Human, Lung Neoplasm, Male, Middle Aged, Prognosi, Reproducibility of Result, Treatment Outcome

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33212418; info:eu-repo/semantics/altIdentifier/wos/WOS:000600546100003; volume:142; firstpage:18; lastpage:28; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11579/125788Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85096157545

    الإتاحة: https://doi.org/10.1016/j.ejca.2020.09.033Test
    http://hdl.handle.net/11579/125788Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

    المؤلفون: Cortellini, Alessio, Di Maio, Massimo, Nigro, Olga, Leonetti, Alessandro, Cortinovis, Diego L, Aerts, Joachim Gjv, Guaitoli, Giorgia, Barbieri, Fausto, Giusti, Raffaele, Ferrara, Miriam G, Bria, Emilio, D'Argento, Ettore, Grossi, Francesco, Rijavec, Erika, Guida, Annalisa, Berardi, Rossana, Torniai, Mariangela, Sforza, Vincenzo, Genova, Carlo, Mazzoni, Francesca, Garassino, Marina Chiara, De Toma, Alessandro, Signorelli, Diego, Gelibter, Alain, Siringo, Marco, Marchetti, Paolo, Macerelli, Marianna, Rastelli, Francesca, Chiari, Rita, Rocco, Danilo, Della Gravara, Luigi, Inno, Alessandro, Michele, De Tursi, Grassadonia, Antonino, Di Marino, Pietro, Mansueto, Giovanni, Zoratto, Federica, Filetti, Marco, Santini, Daniele, Citarella, Fabrizio, Russano, Marco, Cantini, Luca, Tuzi, Alessandro, Bordi, Paola, Minuti, Gabriele, Landi, Lorenza, Ricciardi, Serena, Migliorino, Maria R, Passiglia, Francesco, Bironzo, Paolo, Metro, Giulio, Adamo, Vincenzo, Russo, Alessandro, Spinelli, Gian Paolo, Banna, Giuseppe L, Friedlaender, Alex, Addeo, Alfredo, Cannita, Katia, Ficorella, Corrado, Porzio, Giampiero, Pinato, David J

    المساهمون: Cortellini, Alessio, Di Maio, Massimo, Nigro, Olga, Leonetti, Alessandro, Cortinovis, Diego L, Aerts, Joachim Gjv, Guaitoli, Giorgia, Barbieri, Fausto, Giusti, Raffaele, Ferrara, Miriam G, Bria, Emilio, D'Argento, Ettore, Grossi, Francesco, Rijavec, Erika, Guida, Annalisa, Berardi, Rossana, Torniai, Mariangela, Sforza, Vincenzo, Genova, Carlo, Mazzoni, Francesca, Garassino, Marina Chiara, De Toma, Alessandro, Signorelli, Diego, Gelibter, Alain, Siringo, Marco, Marchetti, Paolo, Macerelli, Marianna, Rastelli, Francesca, Chiari, Rita, Rocco, Danilo, Della Gravara, Luigi, Inno, Alessandro, Michele, De Tursi, Grassadonia, Antonino, Di Marino, Pietro, Mansueto, Giovanni, Zoratto, Federica, Filetti, Marco, Santini, Daniele, Citarella, Fabrizio, Russano, Marco, Cantini, Luca, Tuzi, Alessandro, Bordi, Paola, Minuti, Gabriele, Landi, Lorenza, Ricciardi, Serena, Migliorino, Maria R, Passiglia, Francesco, Bironzo, Paolo, Metro, Giulio, Adamo, Vincenzo, Russo, Alessandro, Spinelli, Gian Paolo, Banna, Giuseppe L, Friedlaender, Alex, Addeo, Alfredo, Cannita, Katia, Ficorella, Corrado, Porzio, Giampiero, Pinato, David J

    مصطلحات موضوعية: immunotherapy, lung neoplasm, Adrenal Cortex Hormone, Adult, Aged, 80 and over, Anti-Bacterial Agent, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Non-Small-Cell Lung, Europe, Female, Human, Immune Checkpoint Inhibitor, Male, Middle Aged, Polypharmacy, Progression-Free Survival, Proton Pump Inhibitor, Retrospective Studie, Risk Assessment, Risk Factor, Time Factors

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33827906; info:eu-repo/semantics/altIdentifier/wos/WOS:000639751500003; volume:9; firstpage:1; lastpage:10; numberofpages:10; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; http://hdl.handle.net/11567/1073070Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103905194

    الإتاحة: https://doi.org/10.1136/jitc-2021-002421Test
    http://hdl.handle.net/11567/1073070Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

    المؤلفون: Cortellini A., Cannita K., Tiseo M., Cortinovis D. L., Aerts J. G. J. V., Baldessari C., Giusti R., Ferrara M. G., D'Argento E., Grossi F., Guida A., Berardi R., Morabito A., Genova C., Antonuzzo L., Mazzoni F., De Toma A., Signorelli D., Gelibter A., Targato G., Rastelli F., Chiari R., Rocco D., Gori S., De Tursi M., Mansueto G., Zoratto F., Filetti M., Bracarda S., Citarella F., Marco R., Cantini L., Nigro O., Buti S., Minuti G., Landi L., Ricciardi S., Migliorino M. R., Natalizio S., Simona C., De Filippis M., Metro G., Adamo V., Russo A., Spinelli G. P., Di Maio M., Banna G. L., Friedlaender A., Addeo A., Pinato D. J., Ficorella C., Porzio G.

    المساهمون: Cortellini, A., Cannita, K., Tiseo, M., Cortinovis, D. L., Aerts, J. G. J. V., Baldessari, C., Giusti, R., Ferrara, M. G., D'Argento, E., Grossi, F., Guida, A., Berardi, R., Morabito, A., Genova, C., Antonuzzo, L., Mazzoni, F., De Toma, A., Signorelli, D., Gelibter, A., Targato, G., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Mansueto, G., Zoratto, F., Filetti, M., Bracarda, S., Citarella, F., Marco, R., Cantini, L., Nigro, O., Buti, S., Minuti, G., Landi, L., Ricciardi, S., Migliorino, M. R., Natalizio, S., Simona, C., De Filippis, M., Metro, G., Adamo, V., Russo, A., Spinelli, G. P., Di Maio, M., Banna, G. L., Friedlaender, A., Addeo, A., Pinato, D. J., Ficorella, C., Porzio, G.

    مصطلحات موضوعية: Immunotherapy, Non-small cell lung cancer, PD-L1, Pembrolizumab, Performance statu, Post-progression, Radiation therapy, Radiotherapy, Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, B7-H1 Antigen, Bone Neoplasm, Carcinoma, Non-Small-Cell Lung, Case-Control Studie, Female, Follow-Up Studie, Human, Liver Neoplasm, Lung Neoplasm, Male, Middle Aged, Prognosi, Retrospective Studie

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33721704; info:eu-repo/semantics/altIdentifier/wos/WOS:000645079600003; volume:148; firstpage:24; lastpage:35; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11567/1073068Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102300170

    الإتاحة: https://doi.org/10.1016/j.ejca.2021.02.005Test
    http://hdl.handle.net/11567/1073068Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

    المؤلفون: Giampiero Porzio, Michele De Tursi, Paolo A. Ascierto, Tea Zeppola, Marcello Tiseo, Daniele Santini, Sebastiano Buti, Francesca Rastelli, Sergio Bracarda, Rossana Berardi, Riccardo Marconcini, Clara Natoli, Andrea De Giglio, Rita Chiari, Cecilia Anesi, Marco Filetti, Federica Zoratto, Rosa Rita Silva, Melissa Bersanelli, Alessio Cortellini, Paolo Marchetti, Raffaele Giusti, Andrea Botticelli, Federica De Galitiis, Alain Gelibter, Corrado Ficorella, Claudia Mosillo, Vito Vanella, Maria Rita Migliorino, Marianna Tudini, Fabiana Perrone, Francesco Atzori, Marco Russano, Biagio Ricciuti, Katia Cannita, Silvia Rinaldi, Domenico Mallardo, Maria Giuseppa Vitale

    المصدر: European Journal of Cancer. 128:17-26

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Programmed Cell Death 1 Receptor, Overweight, Severity of Illness Index, B7-H1 Antigen, Body Mass Index, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Immune-related adverse events, Renal cell carcinoma, Neoplasms, 80 and over, Cancer, Aged, 80 and over, Incidence, Middle Aged, Immunological, BMI, Checkpoint inhibitors, Immunotherapy, Obesity, PD-1/PD-L1, 030220 oncology & carcinogenesis, Female, medicine.symptom, Underweight, Adult, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Aged, Humans, Retrospective Studies, Young Adult, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Adverse effect, business.industry, Retrospective cohort study, medicine.disease, 030104 developmental biology, business, Body mass index

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88fb86092cd1e482e67c1ae96e50babTest
    https://doi.org/10.1016/j.ejca.2019.12.031Test


    أضف إلى المفضلة
  9. 9
    Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression >= 50% and Their Relationship With Clinical Outcomes

    المؤلفون: Raffaele Giusti, Giorgia Guaitoli, Mario Occhipinti, Diego Cortinovis, Ornella Cantale, Luca Cantini, Cinzia Baldessari, Alessio Cortellini, Francesco Grossi, Linda Pettoruti, Vincenzo Sforza, Giovanni Mansueto, Francesco Passiglia, Francesca Mazzoni, Lorenza Landi, Alain Gelibter, Melissa Bersanelli, Daniele Santini, Paolo Marchetti, Alessandro Morabito, Alessandro Leonetti, Marianna Tudini, Serena Ricciardi, Fabrizio Citarella, Ettore D'Argento, Francesca Rastelli, Matteo Santoni, Vincenzo Di Noia, Giampiero Porzio, Robert A. Belderbos, Claudia Proto, Simona Scodes, Marianna Macerelli, Marco Filetti, Joachim G.J.V. Aerts, Diego Signorelli, Luigi Della Gravara, Carlo Genova, Danilo Rocco, Lorenzo Antonuzzo, Alessandro Tuzi, Cristina Cecchi, Luca Sala, Corrado Ficorella, Marco De Filippis, Giuseppe Luigi Banna, Alessandro Inno, Mariangela Torniai, Pamela Pizzutilo, Emilio Bria, Maria Giovanna Dal Bello, Domenico Galetta, Federico Cappuzzo, Federica Bertolini, Rossana Berardi, Maria Rita Migliorino, Miriam Grazia Ferrara, Clelia Donisi, Rita Chiari, Alessandro De Toma, Olga Nigro, Michele Ghidini, Annamaria Catino, Alfredo Addeo, Federica Zoratto, Alessandro Follador, Pietro Di Marino, Alex Friedlaender, Marco Russano, Biagio Ricciuti, Katia Cannita

    المساهمون: Pulmonary Medicine

    المصدر: Clinical Lung Cancer, 21(6), 498-508.e2. Elsevier

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, PD-L1, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, First line, irAEs, NSCLC, Pembrolizumab, Immune checkpoint inhibitors, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, biology, business.industry, Middle Aged, medicine.disease, Prognosis, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, biology.protein, Carcinoma, Squamous Cell, Pd l1 expression, Female, business, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531621b29708da404fb5e5130661d486Test
    https://pure.eur.nl/en/publications/1e14e673-632c-43f9-9fef-78675b6ec8e3Test


    أضف إلى المفضلة
  10. 10
    Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

    المؤلفون: Cecilia Anesi, Paolo Marchetti, Alessio Cortellini, Rossana Berardi, Mario Occhipinti, Marianna Tudini, Francesca Rastelli, Alain Gelibter, Andrea Botticelli, Rosa Rita Silva, Francesca Di Pietro, Paolo A. Ascierto, Giampiero Porzio, Mariangela Torniai, Daniele Santini, Federica De Galitiis, Corrado Ficorella, Federica Pergolesi, Pietro Di Marino, Maria Grazia Vitale, Vito Vanella, Domenico Mallardo, Michele De Tursi, Antonino Grassadonia, Tea Zeppola

    المصدر: Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-6 (2019)
    Journal of Translational Medicine

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Multivariate analysis, Programmed Cell Death 1 Receptor, lcsh:Medicine, Kaplan-Meier Estimate, General Biochemistry, Genetics and Molecular Biology, B7-H1 Antigen, Disease-Free Survival, Young Adult, Renal cell carcinoma, Immune-related adverse events, Internal medicine, Medicine, Humans, Practice Patterns, Physicians', Adverse effect, Fatigue, Aged, Cancer, Aged, 80 and over, IL-6, Performance status, business.industry, Melanoma, Research, lcsh:R, PD-1/PD-L1 inhibitors, General Medicine, Middle Aged, medicine.disease, Clinical trial, IL-6, PD-1/PD-L1 inhibitors, Immunotherapy, Multivariate Analysis, Population study, Female, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4de7dd11433ff59461ffb81d932de7Test
    http://link.springer.com/article/10.1186/s12967-019-02132-xTest


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث